Online
Poll
A Roadmap to Key Pharmacologic Principles in Using Antipsychotics: Application in Clinical Practice
Read this Academic Highlights to discover how the underlying properties of antipsychotics can improve outcomes.
Treating Partial Responders to Antidepressant Treatment
In this case, choose a next-step strategy for a partial responder to treatment, and learn about agents that will facilitate remission.
Is DSM-IV Bereavement Exclusion for Major Depressive Episode Relevant to Severity and Pattern of Symptoms? A Case-Control, Cross-Sectional Study. Emmanuelle Corruble, MD, PhD; Virginie-Anne Chouinard, MD; Alexia Letierce, PhD; Philip A. P. M. Gorwood, MD, PhD; and Guy Chouinard, MD, MSc Pharmacol
[Abstract] [PDF] Posted
6/30/09
Double-Blind Crossover Study of the Cognitive Effects of Lorazepam in Healthy Apolipoprotein E (APOE)-ε4 Carriers. Cynthia M. Stonnington, MD; Peter J. Snyder, PhD; Joseph G. Hentz, MS; Eric M. Reiman, MD; and Richard J. Caselli, MD
[Abstract] [PDF] Posted
6/30/09
Double-Blind Study of Dextroamphetamine Versus Caffeine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder. Lorrin M. Koran, MD; Elias Aboujaoude, MD; and Nona N. Gamel, MSW
[Abstract] [PDF] Posted
6/30/09
Complex Trauma Among Psychiatrically Impaired Children: A Cross-Sectional, Chart-Review Study. Julian D. Ford, PhD; Daniel F. Connor, MD; and Josephine Hawke, PhD
[Abstract] [PDF] Posted
6/30/09
Association of Adverse Childhood Environment With Late-Life Depression. Karen Ritchie, PhD; Isabelle Jaussent, MSc; Robert Stewart, MD, PhD; Anne-Marie Dupuy, MD, PhD; Philippe Courtet, MD, PhD; Marie-Laure Ancelin, PhD; and Alain Malafosse, MD, PhD
[Abstract] [PDF] Posted
6/30/09
Is Psychopharmacologic Treatment Associated With Neuropsychological Deficits in Bipolar Youth? Aude Henin, PhD; Eric Mick, ScD; Joseph Biederman, MD; Ronna Fried, EdD; Dina R. Hirshfeld-Becker, PhD; Jamie A. Micco, PhD; Katherine G. Miller, BA; Caroline C. Rycyna, BA; and Janet Wozniak, MD
[Abstract] [PDF] Posted
6/30/09
Intervention in Individuals at Ultra High Risk for Psychosis: A Review and Future Directions. Patrick D. McGorry, PhD; Barnaby Nelson, PhD; G. Paul Amminger, MD; Andreas Bechdolf, MD; Shona M. Francey, PhD; Gregor Berger, MD; Anita Riecher-Rössler, MD; Joachim Klosterkötter, MD; Stephan Ruhrmann, MD; Frauke Schultze-Lutter, PhD; Merete Nordentoft, PhD; Ian Hickie, MD, FRANZCP; Philip McGuire, MD; Michael Berk, PhD; Eric Y. H. Chen, MD, MRCPscyh, FHKAM; Matcheri S. Keshavan, MD; and Alison R. Yung, MD
[Abstract] [PDF] Posted
6/30/09
A Cross-Sectional Study of Problem and Pathological Gambling in Patients With Schizophrenia/Schizoaffective Disorder. Rani A. Desai, PhD, MPH, and Marc N. Potenza, MD, PhD
[Abstract] [PDF] Posted
6/16/09
Three-Year Follow-Up of Syndromal Antisocial Behavior in Adults: Results From the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Risë B. Goldstein, PhD, MPH, and Bridget F. Grant, PhD, PhD
[Abstract] [PDF] Posted
6/16/09
Cutaneous Adverse Reactions to Psychotropic Drugs: Data From a Multicenter Surveillance Program. Christian Lange-Asschenfeldt, MD; Renate Grohmann, MD; Bernhard Lange-Asschenfeldt, MD; Rolf R. Engel, PhD; Eckart Rüther, MD; and Joachim Cordes, MD
[Abstract] [PDF] Posted
6/16/09
A 6-Month Follow-Up Study of Posttraumatic Stress and Anxiety/Depressive Symptoms in Korean Children After Direct or Indirect Exposure to a Single Incident of Trauma. Boong-Nyun Kim, MD, PhD; Jae-Won Kim, MD, PhD; Hyo-Won Kim, MD; Min-Sup Shin, PhD; Soo-Churl Cho, MD, PhD; Nam Hee Choi, PhD; Hyunnie Ahn, PhD; Seung-Yeon Lee, PhD; Jeong Ryu, MA; and Myoung-Joo Yun, MA
[Abstract] [PDF] Posted
6/16/09
Is Depersonalization Disorder Initiated by Illicit Drug Use Any Different? A Survey of 394 Adults. Daphne Simeon, MD; David S. Kozin, BA; Karina Segal, BSc; and Brenna Lerch, BA
[Abstract] [PDF] Posted
6/16/09
Serotonin Transporter Gene Promoter Polymorphism and Somatoform Symptoms. Anika Hennings; Peter Zill, Dr rer nat; and Winfried Rief, PhD
[Abstract] [PDF] Posted
6/16/09
Bipolar Disorder, Schizoaffective Disorder, and Schizophrenia Overlap: A New Comorbidity Index. Thomas Munk Laursen, PhD; Esben Agerbo, MSc; and Carsten Bøcker Pedersen, MSc
[Abstract] [PDF] Posted
6/16/09
Medication Nonadherence and Treatment Outcome in Patients With Schizophrenia or Schizoaffective Disorder With Suboptimal Prior Response. Jean-Pierre Lindenmayer, M.D.; Hong Liu-Seifert, Ph.D.; Pandurang M. Kulkarni, Ph.D.; Bruce J. Kinon, M.D.; Virginia Stauffer, Pharm.D.; Sara E. Edwards, Pharm.D.; Lei Chen, M.S.; David H. Adams, Ph.D.; Haya Ascher-Svanum, Ph.D.; Peter F. Buckley, M.D.; Leslie Citrome, M.D., M.P.H.; and Jan Volavka, M.D., Ph.D.
[Abstract] [PDF] Posted
6/2/09
Clinical Usefulness of the Diagnostic Manual-Intellectual Disability for Mental Disorders in Persons With Intellectual Disability: Results From a Brief Field Survey. Robert J. Fletcher, D.S.W., A.C.S.W.; Susan M. Havercamp, Ph.D.; Steven L. Ruedrich, M.D.; Betsey A. Benson, Ph.D.; L. Jarrett Barnhill, M.D.; Sally Ann Cooper, M.D.; and Chrissoula Stavrakaki, M.D., Ph.D.
[Abstract] [PDF] Posted
6/2/09
Inflammation and the Phenomenology, Pathophysiology, Comorbidity, and Treatment of Bipolar Disorder: A Systematic Review of the Literature. Benjamin I. Goldstein, M.D., Ph.D.; F.R.C.P.C., David E. Kemp, M.D.; Joanna K. Soczynska, H.B.Sc.; and Roger S. McIntyre, M.D., F.R.C.P.C.
[Abstract] [PDF] Posted
6/2/09
Quetiapine Augments the Effect of Citalopram in Non-Refractory Obsessive-Compulsive Disorder: A Randomized, Double-Blind, Placebo-Controlled Study of 76 Patients. Nienke C. C. Vulink, M.D.; Damiaan Denys, M.D., Ph.D.; Sjoerd B. A. H. A. Fluitman, M.D.; Jantien C. M. Meinardi, M.D.; and Herman G. M. Westenberg, Ph.D.
[Abstract] [PDF] Posted
6/2/09
Treatment Nonadherence and Neurocognitive Impairment in Bipolar Disorder. Anabel Martinez-Aran, Ph.D.; Jan Scott, Ph.D.; Francesc Colom, Ph.D.; Carla Torrent, Ph.D.; Rafael Tabares-Seisdedos, M.D., Ph.D.; Claire Daban, Ph.D.; Marion Leboyer, M.D.; Chantal Henry, M.D.; Guy M. Goodwin, F.Med.Sci., F.R.C.Psych.; Ana Gonzalez-Pinto, M.D., Ph.D.; Nuria Cruz, M.D.; Jose Sanchez-Moreno, Psy.D.; and Eduard Vieta, M.D., Ph.D.
[Abstract] [PDF] Posted
6/2/09
The Maudsley Staging Method for Treatment-Resistant Depression: Prediction of Longer-Term Outcome and Persistence of Symptoms. Abebaw Fekadu, M.D.; Sarah C. Wooderson, Ph.D.; Kalypso Markopoulou, M.D.; and Anthony J. Cleare, Ph.D.
[Abstract] [PDF] Posted
5/19/09
Varenicline Augmentation in Depressed Smokers: An 8-Week, Open-Label Study. Noah S. Philip, M.D.; Linda L. Carpenter, M.D.; Audrey R. Tyrka, M.D., Ph.D.; Laura B. Whiteley, M.D.; and Lawrence H. Price, M.D.
[Abstract] [PDF] Posted
3/24/09
Commentary
782 Defining and Managing Suicidal Risk in Patients Taking Psychotropic Medications. [CME] Jan A. Fawcett, Ross J. Baldessarini, William H. Coryell, Morton M. Silverman, and Dan J. Stein
[PDF]
Original Articles
790 The DEMO Trial: A Randomized, Parallel-Group, Observer-Blinded Clinical Trial of Strength Versus Aerobic Versus Relaxation Training for Patients With Mild to Moderate Depression. Jesper Krogh, Bengt Saltin, Christian Gluud, and Merete Nordentoft
[Abstract]
[PDF]
801 Applicability of a Genetic Signature for
Enhanced Iloperidone Efficacy in the Treatment of Schizophrenia. Simona Volpi, Steven G. Potkin, Anil K. Malhotra, Louis Licamele, and Christian Lavedan
[Abstract]
[PDF]
810 Cataplexy in Anxious Patients: Is Subclinical Narcolepsy Underrecognized in Anxiety Disorders? Dawn L. Flosnik, Bernadette M. Cortese, and Thomas W. Uhde
[Abstract]
[PDF]
817 Pegylated Interferon and Ribavirin–Induced Depression in Chronic Hepatitis C: Role of Personality. Pere Castellvi, Ricard Navinés, Fernando Gutierrez, Dolors Jiménez, Carme Márquez, Susana Subirà, Ricard Solà, and Rocío Martín-Santos
[Abstract]
[PDF]
829 Lurasidone in the Treatment of Acute Schizophrenia: A Double-Blind, Placebo-Controlled Trial. Mitsutaka Nakamura, Masaaki Ogasa, John Guarino, Debra Phillips, Joseph Severs, Josephine Cucchiaro, and Antony Loebel
[Abstract]
[PDF]
837 The Longitudinal Course of Posttraumatic
Stress Disorder Symptom Clusters Among War Veterans. [CME] Zahava Solomon, Danny Horesh, and Tsachi Ein-Dor
[Abstract]
[PDF]
844 Long-Term Safety and Efficacy of Ziprasidone in Subpopulations of Patients With Bipolar Mania. Paul E. Keck, Jr., Marcio Versiani, Lewis Warrington, Antony D. Loebel, and R. Lynn Horne
[Abstract]
[PDF]
852 A Review of Fragile X Premutation Disorders: Expanding the Psychiatric Perspective. James A. Bourgeois, Sarah M. Coffey, Susan M. Rivera, David Hessl, Louise W. Gane, Flora Tassone, Claudia Greco, Brenda Finucane, Lawrence Nelson, Elizabeth Berry-Kravis, Jim Grigsby, Paul J. Hagerman, and Randi J. Hagerman
[Abstract]
[PDF]
863 A Long-Term Trial of the Effectiveness and Safety of Atypical Antipsychotic Agents in Augmenting SSRI-Refractory Obsessive-Compulsive Disorder. Hisato Matsunaga, Toshihiko Nagata, Kazuhisa Hayashida, Kenzo Ohya, Nobuo Kiriike, and Dan J. Stein
[Abstract]
[PDF]
869 Estimating the Risk for Suicide Following the Suicide Deaths of 3 Asian Entertainment Celebrities: A Meta-Analytic Approach. King-wa Fu and Paul S. F. Yip
[Abstract]
[PDF]
879 A Novel Examination of Atypical Major
Depressive Disorder Based on Attachment Theory. Robert D. Levitan, Leslie Atkinson, Rebecca Pedersen, Tom Buis, Sidney H. Kennedy, Kevin Chopra, Eman M. Leung, and Zindel V. Segal
[Abstract]
[PDF]
888 Predictors of Longitudinal Changes in Schizophrenia: The Role of Processing Speed. Pedro Sánchez, Natalia Ojeda, Javier Peña, Edorta Elizagárate, Ana Blanca Yoller,
Miguel Gutiérrez, and Jesús Ezcurra
[Abstract]
[PDF]
897 The Safety, Acceptability, and Effectiveness of Acupuncture as an Adjunctive Treatment for Acute Symptoms in Bipolar Disorder. Ellen B. Dennehy, Rosa Schnyer, Ira H. Bernstein, Robert Gonzalez, Geetha Shivakumar, Dorothy I. Kelly, Diane E. Snow, Suresh Sureddi, and Trisha Suppes
[Abstract]
[PDF]
906 Use of Antipsychotics in the Treatment
of Major Depressive Disorder in the U.S. Department of Veterans Affairs. Somaia Mohamed, Douglas L. Leslie,
and Robert A. Rosenheck
[Abstract]
[PDF]
Focus on Alzheimer's Disease and Related Disorders
913 Introduction. Untangling the Roles of Antidepressants and Mood Stabilizers in the Treatment of Alzheimer's Disease. Eric M. Reiman
[PDF]
915 Effect of a Serotonin Reuptake Inhibitor on Irritability, Apathy, and Psychotic Symptoms in Patients With Alzheimer's Disease. Haroon Siddique, Linda S. Hynan, and Myron F. Weiner
[Abstract]
[PDF]
919 Commentary. Can Lithium or Valproate
Untie Tangles in Alzheimer's Disease? Pierre N. Tariot and Paul S. Aisen
[PDF]
922 Lithium Trial in Alzheimer's Disease:
A Randomized, Single-Blind, Placebo-Controlled, Multicenter 10-Week Study. Harald Hampel, Michael Ewers, Katharina Bürger, Peter Annas, Anette Mörtberg, Anna Bogstedt, Lutz Frölich, Johannes Schröder, Peter Schönknecht, Matthias W. Riepe, Inga Kraft, Thomas Gasser, Thomas Leyhe, Hans-Jürgen Möller, Alexander Kurz, and Hans Basun
[Abstract]
[PDF]
ASCP Corner [PDF]
932 Adding Lithium or Anticonvulsants to Antipsychotics for the Treatment of Schizophrenia: Useful Strategy or Exercise in Futility? Leslie Citrome
Letters To the Editor
934 Long-Term Effects of the Terrorist Attack in Beslan on Adolescent Survivors. Peter G. van der Velden and Joris C. Yzermans
[PDF]
935 Self-Medication, Bipolar Disorders, and
Stimulant Dependence. Edward J. Khantzian and Mark J. Albanese
[PDF]
937 Switching Antipsychotic Medications: A 2-Year Chart-Review Study Exploring Patient Characteristics and Psychiatric Service Use of Schizophrenia Patients. Andrea L. Schneider, Karen E. Mosier, and Raymond P. Tempier
[PDF]
Book Reviews
940 Kaplan and Sadock’s Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry, 10th ed. Ethan Samuel Rofman
[PDF]
940 Mental Health and Violent Youth: A Developmental/Lifecourse Perspective. Michael C. Harlow
[PDF]
941 Clinical Handbook of
Psychiatry and the Law, 4th ed. William Bernet
[PDF]
941 The Guidebook of Sexual Medicine. Robert Taylor Segraves
[PDF]
942 Antipsychotics and Mood Stabilizers: Stahl’s Essential Psychopharmacology, 3rd ed. Henry A. Nasrallah
[PDF]
Electronic CME Activities
Available through www.psychiatrist.com/toc
e16 Treating Depression and Pain. John F. Greden
[Abstract]
e17 Overview of Managing Medical Comorbidities in Patients With Severe Mental Illness. Roger S. McIntyre
[Abstract]
e18 Initial Treatment Approaches for Patients With Major Depressive Disorder. George I. Papakostas
[Abstract]
e19 The Implications of Pain and
Physical Symptoms in Depression. Rakesh Jain
[Abstract]
e20 Augmentation and Combination Strategies
in Resistant Depression. J. Craig Nelson
[Abstract]
SuppleNet | Buy a Single Article
The Journal of Clinical Psychiatry is the official journal of the American Society for Clinical Psychopharmacology
| Online Journal Offerings (choose a year) | ||||||||||
| 2000s | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 |
| 1990s | 1996 | 1997 | 1998 | 1999 | ||||||
Special Sections
Focus on Alzheimer's Disease and Related Disorders
Focus on Childhood and Adolescent Mental Health
Focus on Women's Mental Health
Features
Academic Highlights Feature
Depression and Pain
Pain can be both a symptom and a predictor of depression. Read this Academic Highlights to learn about the common neuropathic pathways shared by pain and depression, understand how pain affects the diagnosis and course of illness in depression, and receive a road map for treating your patients with both of these conditions.
Electronic Activities
Overview of Managing Medical Comorbidities in Patients With Severe Mental Illness
Initial Treatment Approaches for Patients With Major Depressive Disorder
The Implications of Pain and Physical Symptoms in Depression
Augmentation and Combination Strategies in Resistant Depression
SuppleNet Feature
Balancing the Equation: Managing Comorbidities in Patients With Severe Mental Illness
How can you help your patients with schizophrenia or bipolar disorder lead healthier lives? Read this new Supplement and learn what you can do to implement treatment strategies that address modifiable health risk factors and provide a better quality of life for your patients.
JCP CME
Insights Into Generalized Anxiety Disorder
In this Supplement, learn how to manage GAD in the presence of comorbidities and help your patients achieve and retain remission.
Multimedia CME
Pain and the Brain 2: The Recognition and Management of Chronic Pain in Primary Care
NEW! Chronic pain conditions can affect all ages, genders, and ethnicities. In this video, view 3 patient cases and receive expert diagnosis and treatment recommendations for your patients with chronic pain and comorbid conditions.
CME Partners
International Consensus Group on the Evidence-Based Pharmacologic Treatment of Bipolar I and II Depression
Read this Academic Highlights to analyze the available evidence on the treatment of bipolar depression and evaluate how that evidence can be applied in your practice.
Multimedia Curriculum
Definition and Management of Suicidality in Psychiatric Patients
In this activity, review the dangers and benefits of prescribing psychotropic medications and learn how to identify and manage suicidal risk during treatment.
INFORMATION FOR AUTHORS
If your manuscript fits within the scope of the journal, we encourage you to submit. Acceptance is contingent on favorable peer review.
Our user-friendly electronic manuscript submission and peer review system allows you to submit your manuscript online securely, conveniently, and instantly. Authors can track the progress of their manuscripts from submission to publication. Assistance is available via e-mail if needed.
First-time submitters will need to register for an account. After you follow the link above for the submission page, select “New authors should register for an account.” Note that this account is separate from your Net Society account, so even if you are a member of the Net Society (which provides search privileges for our Web site and the ability to obtain free CME credit), you will still need to establish an account to use the manuscript submission system.
Acceptance rate |
31% |
|
No. of articles published per issue |
Mean=16, range=14–22 |
|
Submission-to–first decision time (mean) |
40.9 days |
|
Submission-to–final decision time (mean) |
51.6 days |
|
Submission-to-acceptance time (estimated average) |
4 months |
|
Acceptance-to-publication time |
Mean=5.2 months, |
The Journal of Clinical Psychiatry continues to be ranked as the most-read and 6th most-cited psychiatric journal in the world (according to the Focus Readership Study, June 2007, and Citation Index, July 2007, respectively). The Journal mails to about 35,184 recipients,* and over 20,000 allied mental health professionals have requested daily receipt of informational e-mails about our journals and Web CME activities.
The JCP is also a member of BPA Worldwide and is the official journal of the American Society of Clinical Psychopharmacology, which consists of 800 members who are biopsychiatric researchers, academicians, and clinicians.
*Source: BPA Circulation Statement, June 2007
See the form in PDF format. At the time of article submission, each author must submit a form incorporating 4 statements: (1) authorship, (2) copyright transfer or federal employment, and (3) financial or other relationships that might pose a conflict of interest. The corresponding author must sign (4) the Acknowledgment statement. This form can be mailed to Physicians Postgraduate Press, P.O. Box 752870, Memphis, TN 38175-2870, faxed to the Production Coordinator at 901-273-2752, or scanned and uploaded during the electronic submission process.
See the checklist.
See the guidelines.
Authors receive a complimentary copy of the issue in which their article or letter appears and are sent a reprint order form at the time their article is published.
Authors can also order single copies of articles or back issues, as well as larger quantities of high-quality photocopies or reprints. Learn more about reprints.
See the clinical trials registration information in our Information for Authors.
Material published in the Journal is embargoed until the 15th of the month of issue. Contact .
INFORMATION FOR REVIEWERS
Manuscripts that meet the Journal’s scope and submission criteria are sent to expert consultants for peer review.
Reviewers who have a financial or personal conflict of interest related to a manuscript are obligated to decline the reviewer position.
The peer review process is conducted using the electronic submission system used for manuscripts. Potential reviewers are queried in advance about their availability. While reviewers are asked to complete their reviews within 3 weeks of receiving the manuscript, more expeditious turnaround is highly valued. If you would like to be a peer reviewer, please send your CV to .
The reviewers' identities are not revealed, and strict confidentiality regarding the submitted manuscript is maintained. Reviewers must not keep copies of the manuscripts they review or discuss any of the information or data with others.
Peer review is essential to a medical journal, and each year, those peer reviewers who have carried the heaviest load and reviewed the greatest number of manuscripts are recognized as members of the Journal’s Circle of Honor.
The Circle of Honor is the Journal’s acknowledgment of the indispensable contribution—the dedication, scholarship, and scientific rigor—generously donated by these individuals.
2006 Circle of Honor
James Dalen, M.D., M.P.H.
James H. Kocsis, M.D.
David C. Emelity, M.D.
Francisco A. Moreno, M.D.
Maurizio Fava, M.D.
Michael K. Popkin, M.D.
Marlene P. Freeman, M.D.
George M. Simpson, M.D.
Scott A. Freeman, M.D.
Michael E. Thase, M.D.
Anne Herring, R.N., Ph.D.
Mauricio F. Tohen, M.D., Dr.P.H.
David B. Herzog, M.D.
James W. Jefferson, M.D.
Carlos A. Zarate, Jr., M.D.
John M. Kane, M.D.
Mark Zimmerman, M.D.
Samuel J. Keith, M.D.
Psychiatrist.com Home
Keyword Search